Boundless Bio Inc.

NASDAQ: BOLD · Real-Time Price · USD
1.16
-0.01 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
1.16
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Boundless Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.09M 957K 942K 682K
Gross Profit
-1.09M -957K -942K -682K
Operating Income
-73.27M -54.8M -46.47M -25.3M
Interest Income
7.89M 5.28M 668K 96K
Pretax Income
-65.36M -49.43M -45.9M -25.21M
Net Income
-65.36M -49.43M -45.9M -25.21M
Selling & General & Admin
18M 12.16M 9.31M 6.02M
Research & Development
55.27M 41.68M 37.16M 19.28M
Other Expenses
-1.09M n/a -100K -5K
Operating Expenses
72.18M 54.8M 46.47M 25.3M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
73.27M 54.8M 46.47M 25.3M
Income Tax Expense
n/a n/a n/a -96K
Shares Outstanding (Basic)
16.98M 22.24M 22.24M 22.24M
Shares Outstanding (Diluted)
16.98M 22.24M 22.24M 22.24M
EPS (Basic)
-3.85 -2.22 -2.06 -1.13
EPS (Diluted)
-3.85 -2.22 -2.06 -1.13
EBITDA
-64.28M -48.48M -45.53M -24.62M
EBIT
-65.36M -49.43M -45.9M -25.21M
Depreciation & Amortization
1.09M 957K 942K 682K